Research Paper Volume 16, Issue 3 pp 2090—2122
MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis
Figure 6. Association between MAEL expression and immune cell signatures in advanced/metastatic ccRCCs. (A–C) Association between MAEL expression and immune cell signatures in the JAVELIN Renal 101 cohort (A), the CheckMate-025 cohort (B), and the stage IV ccRCC patients in the TCGA-KIRC cohort (C). Abbreviations: MDSC=myeloid-derived suppressor cell, TCGA-KIRC=The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma.